Some of them have.
Again, another aspect of the guidelines that I wasn't able to get into is the impact of that Federal Court decision that I mentioned. Going forward, until we have clarity from the Federal Court of Appeal and it reverses the decision at trial, the only price ceiling that these medications will be subject to is the median international price. I don't think it's unreasonable to expect pharmaceutical companies—some of the most profitable industry sectors in the global economy—to be able to bring drugs to Canada at a price that's more aligned with the international median. Canada is not alone—